Targeted drug delivery system for brain glioma as well as preparation method and use thereof

A glioma and nano-drug delivery system technology is applied to the glioma targeted drug delivery system modified by nucleic acid aptamer AS1411 and the field of preparation thereof, and can solve the problem of low drug loading, neurotoxicity and side effects, and excipients. Problems such as large injection dose to achieve the effect of inhibiting tumor growth and enhancing the inhibitory effect

Inactive Publication Date: 2016-12-14
EAST CHINA NORMAL UNIVERSITY
View PDF0 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, this preparation still has the disadvantages of low drug loading and large injection dose of excipients, which leads to strong systemic toxicity and side effects, and its curative effect needs to be further improved.
At present, there are still many problems in the treatment of brain tumors in the paclitaxel nano-delivery system: due to the hindering effect of the blood-brain barrier, it is difficult for 98% of small-molecule drugs and almost all mac

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Targeted drug delivery system for brain glioma as well as preparation method and use thereof
  • Targeted drug delivery system for brain glioma as well as preparation method and use thereof
  • Targeted drug delivery system for brain glioma as well as preparation method and use thereof

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0049] Example 1

[0050] Preparation of polyglutamic acid PGG:

[0051] 1) The sodium polyglutamate cPGA-Na (molecular weight 35000, 10g), tert-butyl glutamate hydrochloride H-Glu (otBu) 2 ·HCl (38.3g, 0.148mol), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride EDC·HCl (37.0g, 0.193mol), 1-hydroxybenzo Triazole HOBt (10.6g, 0.074mol) was dissolved in 500mL of anhydrous N,N-dimethylformamide DMF, magnetically stirred at 700rpm at 25°C for 24h, and protected by argon. The reacted solution was slowly poured into 3L of deionized water, a white precipitate was deposited, filtered, washed with 250mL of deionized water 3 times, and freeze-dried for 15 hours to obtain a white solid.

[0052] 2) Transfer the product (60 g) obtained in step 1) to a 1 L round bottom flask, add 480 mL of trifluoroacetic acid TFA, and magnetically stir at 700 rpm at 25° C. for 4 hours. TFA was removed by vacuum rotary evaporation at 40°C to obtain a yellow oil. After repeating this step twice, 800 m...

Example Embodiment

[0053] Example 2

[0054] Preparation of polyglutamic acid PGG-PTX:

[0055] Polyglutamine glutamic acid PGG (10g), add 500mL anhydrous N,N-dimethylformamide DMF, 25℃, 700rpm magnetic stirring for 30min until completely dissolved, then add 1-(3-dimethylaminopropyl) Yl)-3-ethylcarbodiimide hydrochloride EDC·HCl (9.4g, 0.049mol) and 4-lutidine (2.6g), and continue to stir for 15 min. Add paclitaxel PTX (5.4g) into the reaction flask and stir it magnetically at 700rpm at 25℃ for 26-28h. After the reaction is complete, slowly pour the reaction solution into 1.5L hydrochloric acid aqueous solution (0.2M) in an ice bath environment, and a white precipitate separates out at 5000rpm After centrifugation for 10 min, the white precipitate obtained was dissolved in 1.5L of sodium bicarbonate (0.5M) aqueous solution, and then transferred to a dialysis bag (with a molecular weight cut-off of 10000) for 24 hours, during which all deionized water was replaced every 4 hours. When the resistivity...

Example Embodiment

[0057] Example 3

[0058] Preparation of aptamer AS1411 modified polyglutamine glutamate-paclitaxel covalent bond AS1411-PGG-PTX:

[0059] 1) Take 8mg (10nmol) of polyglutamine glutamate-paclitaxel covalent bond PGG-PTX and dissolve in 1mL of 2-(N-morpholine) ethanesulfonic acid buffer solution MES buffer (pH 6.0, 0.1M) , Where the concentration of PGG-PTX is 10μM. Then add 200mM 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride EDC·HCl and 200mM N-hydroxysuccinimide NHS successively, and stir with magnetic force at 400rpm at 25℃. After 30 minutes, the carboxyl groups on the surface of PGG-PTX are activated, and the mixed solution changes from transparent and clear to white and turbid.

[0060] 2) Transfer the solution obtained in step 1) to a 4mL ultrafiltration tube (molecular weight cut-off: 30000), and wash with DNA / RNase-free distilled water DNase / RNase free water to remove EDC / NHS. The amount of DNase / RNase free water is 4mL / Time, centrifugal force is 2500g, 5min / ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Molecular weightaaaaaaaaaa
Login to view more

Abstract

The invention discloses a targeted drug delivery system for a brain glioma, as well as a preparation method and use of the targeted drug delivery system for the brain glioma. The drug delivery system comprises targeting molecules, a polymer carrier and a drug, wherein the targeting molecules are aptamers AS1411, the polymer carrier is PGG (polyclonal gamma globulin), and the drug is PTX (paclitaxel); PGG and PTX are combined to a PGG-PTX covalent bond complex through a covalent bond; the aptamers AS1411 are covalently linked with carboxyls on the surface of PGG-PTX through primary amino modified by the 5'ends of the aptamers AS1411 to form an AS1411-PGG-PTX covalent bond complex modified by the aptamers AS1411 which has a structure of the following formula. The targeted drug delivery system disclosed by the invention can target brain glioma tissues and neovascular endothelial cells simultaneously to effectively improve the drug accumulation in tumor sites and increase the drug concentration in tumor cells so as to enhance the antitumor treatment effect of the drug. The targeted drug delivery system is easily and automatically assembled into nanoparticles to improve the accuracy of PTX chemotherapy and reduce side effects of PTX in clinical application.

Description

technical field [0001] The invention belongs to the field of pharmaceutical preparations, and relates to a brain-targeted drug delivery system, in particular to a brain glioma-targeted drug delivery system modified by nucleic acid aptamer AS1411 and a preparation method thereof. The drug delivery system can target brain glioma tissue and neovascular endothelial cells at the same time, effectively improve the accumulation of drugs in the tumor site, thereby improving the effect of chemotherapy. Background technique [0002] According to the statistics of the World Health Organization, the global incidence of malignant brain tumors is 3.5 / 100,000, among which Glioblastoma multiforme (GBM) is one of the most common primary malignant tumors with the highest mortality in the brain , accounting for about 40% of the incidence of brain tumors, the average survival period is only 14 months. The traditional clinical treatment method is surgical resection, but because the brain tumor ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K47/48A61K31/337A61P35/00
CPCA61K31/337
Inventor 俞磊罗子淼庞志清闫志强王镜朱建中王依婷
Owner EAST CHINA NORMAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products